Search Results: United Kingdom (7)
-
Today Dr Tedros Adhanom Ghebreyesus, WHO Director-General, and Dr Ursula von der Leyen, President of the European Commission, co-hosted the inaugural meeting of the Access to COVID-19 Tools (ACT) Accelerator Facilitation Council.
Roles: Everyone: All Users
Regions: Canada , China, France , Italy , Norway , Rwanda , South Africa , United Kingdom , Uzbekistan
Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health
-
The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.
One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T
Roles: Everyone: All Users
Regions: Canada , France , Italy , United Kingdom
Topics: Global Health
-
- Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
- 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor
Roles: Everyone: All Users
Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia
Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation
-
Snakebite envenoming is a common problem in many parts of the world, but little
is known about its magnitude in the Arab countries of the Middle East,
where cases are not widely reported. The aim is to halve the numbers of deaths and cases of disability due to snakebite envenoming over the next 12 years through a programme that targets affected communities and their health systems, and by ensuring access to safe, effective treatment through increased cooperation, collaboration and partnership at all leve
Roles: Everyone: All Users
Regions: Jordan , Kuwait , Syria , United Kingdom , Yemen
Topics: Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation
-
Launching today, the COVID-19 Law Lab initiative gathers and shares legal documents from over 190 countries across the world to help states establish and implement strong legal frameworks to manage the pandemic. The goal is to ensure that laws protect the health and wellbeing of individuals and communities and that they adhere to international human rights standards.
The new Lab (at www.COVIDLawLab.org) is a joint project of United Nations D
Roles: Everyone: All Users
Regions: United Kingdom
Topics: Climate and Environment, Combating Drugs and Crime, Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation
-
- Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)
- The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic
- Interest from governments represen
Roles: Everyone: All Users
Regions: Argentina, Canada , Norway , United Kingdom
Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation
-
A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.
Roles: Everyone: All Users
Regions: United Kingdom
Topics: Global Health, Science, Technology, and Innovation